首页 | 本学科首页   官方微博 | 高级检索  
     


Management and treatment of glomerular diseases (part 2): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Authors:Brad H. Rovin  Dawn J. Caster  Daniel C. Cattran  Keisha L. Gibson  Jonathan J. Hogan  Marcus J. Moeller  Dario Roccatello  Michael Cheung  David C. Wheeler  Wolfgang C. Winkelmayer  Jürgen Floege
Affiliation:1. Division of Nephrology, The Ohio State University, Wexner Medical Center, Columbus, Ohio, USA;2. Department of Medicine, University of Louisville School of Medicine, Louisville, Kentucky, USA;3. Toronto General Research Institute, University Health Network, Toronto, Ontario, Canada;4. University of North Carolina Kidney Center at Chapel Hill, Chapel Hill, North Carolina, USA;5. Division of Nephrology, University of Pennsylvania, Philadelphia, Pennsylvania, USA;6. Division of Nephrology and Clinical Immunology, Rheinisch-Westfälische Technische Hochschule, University of Aachen, Aachen, Germany;7. CMID (Center of Research of Immunopathology and Rare Diseases), and Division of Nephrology and Dialysis (ERK-Net member), University of Turin, Italy;8. KDIGO, Brussels, Belgium;9. University College London, London, UK;10. Selzman Institute for Kidney Health, Section of Nephrology, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA;11. Division of Nephrology, Rheinisch-Westfälische Technische Hochschule, University of Aachen, Aachen, Germany
Abstract:
Keywords:anti-neutrophil cytoplasmic antibody–associated vasculitis  C3 glomerulopathy  focal and segmental glomerulosclerosis  KDIGO  lupus nephritis  membranoproliferative glomerulonephritis  minimal change disease  monoclonal gammopathies of renal significance
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号